切片檢查設備市場報告：2030 年趨勢、預測與競爭分析

切片檢查設備趨勢和預測

預計到 2030 年，全球切片檢查設備市場將達到 37 億美元，2024 年至 2030 年複合年成長率為 6.6%。該市場的主要促進因素是癌症發病率上升和對微創手術的需求不斷增加。全球切片檢查設備市場的未來充滿希望，乳房切片、切片檢查、結腸切片檢查和前列腺切片檢查市場充滿機會。

• Lucintel 預測，在產品類型中，針活體組織切片設備預計將在預測期內實現最高成長。
• 從應用來看，乳房切片預計將在預測期內出現最高成長。
• 從地區來看，預計北美將在預測期內實現最高成長。

切片檢查設備市場的策略性成長機會

隨著技術的發展和醫療保健需求的不斷成長，切片檢查設備市場在多種應用中提供了眾多的成長領域。這些機會凸顯了該行業改進和擴展的潛力。

• 癌症診斷的成長：越來越多的癌症患者需要先進的切片檢查設備來提高早期癌症檢測率。這些機會包括引入新技術，提高精確度，同時降低手術風險，以及針對腫瘤族群的更好方法。這一不斷發展的領域對於加強癌症控制和管理至關重要。
• 開發攜帶式解決方案：可攜式且價格實惠的切片檢查設備的出現顯示出巨大的成長潛力，特別是在低收入者身上。更小、更具成本效益的設備的技術進步對於增加切片檢查的採用至關重要，從而消除醫療保健服務的差異並能夠更早發現不同人群的疾病。
• 與數位健康平台整合：將無線切片檢查設備整合到數位健康基礎設施中，包括遠端醫療和電子健康記錄，為豐富患者護理、監測和診斷提供了機會。這些應用程式可以在就診之間收集資料，並促進改善臨床協作。
• 微創技術：對減少疼痛和縮短治療時間的非侵入性切片檢查技術的需求顯著增加。顯然，存在增強無針切片檢查系統和勒除器技術的機會，以改善患者在臨床環境中的體驗。
• 機器人輔助切片檢查的進展：使用機械臂促進切片檢查程序的系統的成長機會凸顯了提高這些系統準確性的機會。機器人技術可以準確地瞄準關注的器官進行診斷和治療，透過減少與傳統治療相關的副作用來改善患者護理，並鼓勵醫院廣泛採用機器人技術。

這些策略顯示瞭如何在切片檢查設備市場上實現進一步的創新和增強。專注於癌症診斷、可攜式設備、數位健康、微創策略和機器人系統的進步將創造新的機會，提高客戶滿意度並促進經濟發展。

切片檢查設備市場促進因素與挑戰

切片檢查設備市場受到各種技術、經濟和監管促進因素和挑戰的顯著影響。科技的發展正在帶來更準確、更快速的切片檢查。經濟因素與地理准入和市場成長有關。法律問題影響新設備的創建和生產。

推動切片檢查設備市場的關鍵因素是：

• 技術因素：技術進步是切片檢查設備市場的關鍵促進因素。人工智慧影像判讀、機器人輔助手術和改進的顯像模式等突破性技術使切片檢查程序更快、更準確、侵入性更小。此類技術可以實現更準確的組織採樣和有效的診斷，從而在切片檢查過程中更多地使用先進的醫療設備。持續的技術進步預計將擴大切片檢查設備的功能並拓寬其應用。
• 癌症患者的增加：癌症發生率的增加推動了對更好的切片檢查設備的需求。人們越來越重視早期、準確的檢測以進行有效的治療。對先進切片檢查技術的需求正在推動癌症診斷中設備性能和有效性的提高。癌症盛行率的不斷增加需要開發新的切片檢查技術來滿足產業需求。
• 對微創治療的偏好：微創手術影響切片檢查設備市場的成長。無針活體組織切片和內視鏡切片檢查等技術可提高患者的舒適度並縮短復原時間，而不會影響診斷品質。這種侵入性較小的趨勢導致了新技術的引入，改善了患者的體驗並擴大了切片檢查的應用。

切片檢查設備市場的挑戰包括：

• 先進設備價格昂貴：技術障礙阻礙了新引進的切片檢查設備的廣泛採用，特別是在新興國家。開發和生產最尖端科技涉及大量成本，這些成本最終轉嫁給最終用戶。這些挑戰可能會影響先進切片檢查設備的市場滲透率，並限制其在某些地區或醫療環境中的使用。
• 監管問題：監管障礙可能會阻礙新切片檢查設備的進步。規格和要求因地區而異，這可能會延遲新技術的引入。法規遵循對於設備安全性和有效性至關重要，但也可能成本高且耗時。監管問題可能會限制用戶快速獲得先進的切片檢查設備。
• 資料隱私和安全問題：收集病患資料的切片檢查設備和系統必須解決隱私和安全問題。保護敏感資訊（包括社交資料和病歷）、維護病患機密並遵守隱私法規至關重要。這些挑戰需要加強安全措施並遵守資料保護條例，使切片檢查設備的製造和引入變得複雜。

目錄

第1章執行摘要

第2章全球切片檢查設備市場：市場動態

• 簡介、背景、分類
• 供應鏈
• 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

• 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
• 全球切片檢查設備市場趨勢（2018-2023）與預測（2024-2030）
• 按產品分類的全球切片檢查設備市場
  • 針吸切片裝置
  • 定位線
  • 治療托盤
  • 其他
• 按指導方法分類的全球切片檢查設備市場
  • 超音波切片檢查
  • 立體定位切片檢查
  • MRI導引切片檢查
  • 其他
• 全球切片檢查設備市場（按應用）
  • 乳房切片
  • 切片檢查
  • 結腸切片檢查
  • 攝護腺切片檢查
  • 其他
• 按最終用途分類的全球切片檢查設備市場
  • 醫院
  • 學術研究所
  • 診斷/影像診斷中心

第4章 2018-2030年區域市場趨勢及預測分析

• 按地區分類的全球切片檢查設備市場
• 北美切片檢查設備市場
• 歐洲切片檢查設備市場
• 亞太切片檢查設備市場
• 其他區域切片檢查設備市場

第5章 競爭分析

• 產品系列分析
• 營運整合
• 波特五力分析

第6章 成長機會與策略分析

• 成長機會分析
  • 按產品分類的成長機會
  • 指導方法的成長機會
  • 按應用分類的成長機會
  • 按最終用途分類的成長機會
  • 按地區分類的成長機會
• 全球切片檢查設備市場的新興趨勢
• 戰略分析
  • 新產品開發
  • 擴大全球切片檢查設備市場的產能
  • 全球切片檢查設備市場的合併、收購和合資企業
  • 認證和許可

第7章主要企業概況

• Cook Medical
• Boston Scientific
• Fujifilm
• Cardinal Health
• Danaher

Biopsy Device Trends and Forecast

The future of the global biopsy device market looks promising with opportunities in the breast biopsy, lung biopsy, colorectal biopsy, and prostate biopsy markets. The global biopsy device market is expected to reach an estimated $3.7 billion by 2030 with a CAGR of 6.6% from 2024 to 2030. The major drivers for this market are the rising prevalence of cancer and the increasing demand for minimally invasive procedures.

• Lucintel forecasts that, within the product category, needle-based biopsy instrument is expected to witness the highest growth over the forecast period.
• Within the application category, breast biopsy is expected to witness the highest growth over the forecast period.
• In terms of regions, North America is expected to witness the highest growth over the forecast period.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Biopsy Device Market

Like any other market, the biopsy device market is changing in several ways due to the emergence of key trends and shifts in the financial industry. These trends are defining the future of biopsy techniques and their applications.

• Integration of Artificial Intelligence: The incorporation of AI in biopsy devices is aiding in achieving accurate diagnoses through efficient analysis of image data and characterization of tissues. Vast amounts of data can be analyzed by AI models, patterns can be established, and abnormalities that would ordinarily go unnoticed can be flagged. These trends aim to provide more accurate and precise outcomes from biopsy procedures, minimizing the likelihood of misdiagnosis and enhancing patient health.
• Techniques that are Less Severely Invasive: There is an increasing focus on less invasive biopsy techniques to alleviate pain and reduce recovery time for patients. New developments, such as needleless biopsies and more sophisticated endoscopic techniques, are decreasing the invasiveness of procedures without compromising diagnostic quality. This shift enhances patient experience and broadens the scope of biopsies in various clinical contexts.
• Core Biopsy Synthesis with Imaging Techniques: New imaging technologies, such as real-time ultrasound and MRI, which were previously external to biopsy systems, are now being integrated into biopsy devices to improve targeting and accuracy. These integrations enhance target tissue visualization, augmenting the efficiency of tissue sampling and limiting risks associated with procedures. This development is making biopsies increasingly efficient and improving diagnoses.
• Mobile and Affordable Devices: The technology is moving toward the development of small, affordable biopsy devices that are easy to use at the point of care. The reduction in size and cost of technology facilitates biopsy performance in various locations and addresses imbalances in healthcare systems by improving rates of early identification and diagnosis among different demographics.
• Robotic-Assisted Biopsies: Robotic-assisted systems are providing necessary measures of accuracy and intervention during biopsy processes. These systems increase the precision of tissue sampling and reduce the chances of human error. The use of robotics is making biopsies more standardized and accurate, thereby improving the efficiency and effectiveness of procedures and enhancing patient outcomes.

The current trends in the biopsy device market are aimed at improving accuracy, safety, and ease of use. The integration of AI, less invasive approaches, imaging technologies, compact size, and robotics technology is enhancing productivity and revolutionizing biopsy technologies, thus improving the quality of diagnosis and healthcare.

Recent Developments in the Biopsy Device Market

Recent developments in the biopsy device market highlight significant advancements that make biopsy procedures more accurate, easier, and effective. These improvements are driven by technological growth in medicine and healthcare.

• Artificial Intelligence for Image Diagnostics: AI is penetrating the biopsy device arena to advance diagnostic accuracy. Sophisticated algorithms process images acquired from biopsies to detect and classify tissue lesions accurately. This step reduces the incidence of diagnostic failures and ensures findings are of appropriate quality, enhancing patient care and improving treatment choices.
• Development of Robotic Systems: The enhancement of robotic systems in biopsy procedures is ongoing. These advanced systems are more effective in tissue sampling and minimizing factors associated with human error. By taking over the most complicated aspects of biopsies, robotic systems enhance the reproducibility and reliability of outcomes, which in turn facilitates better diagnosis and treatment of diseases.
• Consideration for Less Painful Biopsy Types: Applying minimally invasive biopsy techniques decreases patient suffering and healing time. More efficient methods, such as needleless biopsies and endoscopic approaches, are reducing the invasiveness of procedures without compromising diagnostic effectiveness. These improvements contribute to better patient care and expand indications for biopsies in various clinical practices.
• Biopsy Miniaturization and Development of Portable Biopsy Devices: Portable biopsy devices are transforming the landscape of biopsy procedures, even in rural and underserved regions. These devices are small, and affordable, and provide services usually unavailable in clinics, reducing the need for travel for medical attention.
• Real-Time Imaging Integration: Improved integration of real-time imaging systems, such as ultrasound or MRI, with biopsy devices is increasing procedural accuracy. Real-time imaging enhances visualization of the site of interest, facilitating better sampling and reducing risks associated with procedures. This development leads to increased efficacy and accuracy of biopsies.

These novel changes are revolutionizing the biopsy device market, making procedures more effective, less invasive, and easier to access. The incorporation of AI, robotic systems, minimally invasive approaches, portability, and real-time imaging are all factors shaping progress and enhancing the effectiveness of biopsy procedures.

Strategic Growth Opportunities for Biopsy Device Market

In the context of technological developments and increasing healthcare demands, the biopsy device market offers numerous growth areas across several applications. These opportunities highlight the potential for improvement and expansion in the industry.

• Growth in Cancer Diagnostics: The rising number of cancer cases necessitates advanced biopsy devices to improve early cancer detection rates. Opportunities include introducing new technologies that enhance accuracy while decreasing procedural risks, as well as better methods of targeting tumor populations. This growth area is vital for enhancing cancer control and management.
• Development of Portable Solutions: The emergence of portable and affordable biopsy devices presents significant growth potential, especially in low-income areas. Technological advancements in smaller, cost-effective devices are essential for increasing biopsy utilization rates, thereby closing gaps in healthcare services and enabling early disease detection across various populations.
• Integration with Digital Health Platforms: Integrating wireless biopsy instruments into digital health infrastructures, including telehealth and electronic personal health records, presents opportunities for enriching patient care, monitoring, and diagnostics. These applications enable data collection between visits and facilitate improved inter-clinical collaboration.
• Minimally Invasive Technologies: There has been a notable increase in the demand for non-intrusive biopsy techniques that reduce pain and healing times. There are clear opportunities to enhance needle-free biopsy systems and snare techniques, improving patient experiences in clinical settings.
• Advancements in Robotic-Assisted Biopsies: The growth of systems that facilitate biopsy procedures through robotic arms highlights opportunities for improving the accuracy of these systems. Robotic technology can accurately target the organ of concern during diagnosis and treatment, thereby improving patient care by reducing side effects associated with previous treatments and encouraging wider adoption of robotics in hospitals.

These strategies suggest how further innovations and enhancements can be achieved in the biopsy device market. Focusing on advances in cancer diagnostics, portable devices, digital health, minimally invasive strategies, and robotic systems will entrench new opportunities, enhance customer satisfaction, and promote economic development.

Biopsy Device Market Driver and Challenges

The biopsy device market is significantly impacted by various technological, economic, and regulatory drivers and challenges. Technological developments are leading to more accurate and faster biopsies. Economic factors are linked to geographical access and market growth. Legal concerns influence the creation and production of new devices.

The key factors driving the biopsy device market include:

• Technological Factors: Technological advancements are key drivers in the biopsy device market. Breakthroughs such as AI image interpretation, robot-assisted surgery, and improved imaging modalities enhance the speed and accuracy of biopsy procedures while making them minimally invasive. Such technologies allow for more precise tissue sampling and effective diagnosis, leading to increased utilization of sophisticated medical equipment in biopsy procedures. Ongoing technological advancements are expected to expand the functions of biopsy devices and broaden their applications.
• Increasing Cases of Cancer: The rising incidence of cancer is driving demand for better biopsy devices. There is a growing emphasis on early and accurate detection for effective treatment. The need for advanced biopsy technologies is prompting improvements in device performance and effectiveness in cancer diagnosis. The increasing prevalence of cancer necessitates the development of new biopsy technologies to meet industry demand.
• Preference for Minimally Invasive Procedures: Minimally invasive procedures influence the growth of the biopsy device market. Techniques such as needle-free and endoscopic biopsies enhance patient comfort and shorten recovery times without compromising diagnostic quality. This trend toward reduced invasiveness is leading to the introduction of new technologies that improve patient experiences and widen the applications for biopsies.

Challenges in the biopsy device market include:

• Advanced Devices Are Expensive: Technology barriers hinder the uptake of newly introduced biopsy devices, particularly in developing countries. There is a significant cost associated with the development and production of cutting-edge technologies, which is ultimately passed on to the end user. These challenges affect the market penetration of advanced biopsy devices and may restrict their use in certain geographical or medical contexts.
• Regulatory Issues: Regulatory hurdles can impede the progress of new biopsy devices. The diverse specifications and requirements across regions can delay the introduction of new technologies. While addressing regulations is essential for the safety and effectiveness of devices, it can also be costly and time-consuming. Regulatory issues may limit the rapid access of advanced biopsy devices to users.
• Data Privacy and Security Concerns: Biopsy devices and systems that collect patient data must address privacy and security issues. It is crucial to protect sensitive information, including social data and medical histories, to maintain patient confidentiality and comply with privacy regulations. These challenges necessitate enhanced security measures and compliance with data protection regulations, complicating the manufacturing and introduction of biopsy devices.

Factors such as the growth of innovative technologies, increasing cancer rates, rising interest in non-invasive procedures, a burgeoning market for personalized medicine, and improved healthcare infrastructure are promoting growth in the biopsy device market. However, challenges such as high costs, regulatory barriers, and data privacy concerns must be addressed to facilitate technology acceptance and operational efficiency. Striking a balance between innovation and these hurdles is vital for advancing biopsy procedures while safeguarding patient interests.

List of Biopsy Device Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies biopsy device companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the biopsy device companies profiled in this report include-

• Cook Medical
• Boston Scientific
• Fujifilm
• Cardinal Health
• Danaher

Biopsy Device by Segment

The study includes a forecast for the global biopsy device by product, guidance technique, application, end use, and region.

Biopsy Device Market by Product [Analysis by Value from 2018 to 2030]:

• Needle-Based Biopsy Devices
• Localization Wires
• Procedure Trays
• Others

Biopsy Device Market by Guidance Technique [Analysis by Value from 2018 to 2030]:

• Ultrasound-Guided Biopsy
• Stereotactic-Guided Biopsy
• MRI-Guided Biopsy
• Others

Biopsy Device Market by Application [Analysis by Value from 2018 to 2030]:

• Breast Biopsy
• Lung Biopsy
• Colorectal Biopsy
• Prostate Biopsy
• Others

Biopsy Device Market by End Use [Analysis by Value from 2018 to 2030]:

• Hospitals
• Academic and Research Institutes
• Diagnostic and Imaging Centers

Biopsy Device Market by Region [Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Biopsy Device Market

The latest trends in biopsy devices reflect overall developments in the medical device domain, emphasizing accuracy, minimization of invasiveness, and integration of digital features. These enhancements are poised to improve diagnostic and therapeutic activities worldwide.

• United States: In the U.S., biopsy devices have advanced significantly, particularly in robotic surgical systems. For example, the technological advancements by Intuitive Surgical and Medtronic have focused on precision and minimizing patient discomfort. Technologies incorporating AI to analyze images for diagnostic purposes have also been developed. These innovations improve biopsy procedures, reduce procedural risks, and shorten patient recovery times.
• China: China's biopsy device market is expanding beyond simple biopsy techniques to incorporate artificial intelligence into device designs. Many companies are offering equipment that employs AI principles to sample tissues more accurately. Additionally, efforts are being made to make these technologies affordable, ensuring accessibility for rural populations. Advances in healthcare device manufacturing in China are improving public health and increasing access to high-quality diagnostics.
• Germany: Germany leads in the development of advanced biopsy technologies, focusing on accuracy and automation. The emergence of multifunctional, high-resolution imaging systems and automated biopsy devices is reducing the likelihood of human error. German companies are also working on integrating biopsy devices with electronic health records to improve clinical management. These advancements are streamlining biopsy processes, enhancing efficiency, and improving healthcare quality in both clinical and research settings.
• India: In India, new biopsy devices are evolving to include affordable and lightweight options suitable for diverse work environments. Companies and research institutions are developing low-cost biopsy technologies that can be utilized in rural areas and are user-friendly. This focus on affordability and ease of use aims to enhance early cancer detection and address healthcare challenges in many parts of the country.
• Japan: Japan is advancing biopsy devices equipped with modern imaging and robotic technologies. Japanese industries are developing systems that offer real-time imaging and robotic assistance to facilitate biopsy procedures. There are also efforts to integrate these systems with telemedicine platforms for remote consultation and diagnosis. These initiatives aim to improve diagnostic accuracy and effectiveness while ensuring robust health technology within Japan's healthcare system.

Features of the Global Biopsy Device Market

Market Size Estimates: Biopsy device market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Biopsy device market size by various segments, such as by product, guidance technique, application, end use, and region in terms of value ($B).

Regional Analysis: Biopsy device market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, guidance techniques, applications, end uses, and regions for the biopsy device market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the biopsy device market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the biopsy device market by product (needle-based biopsy devices, localization wires, procedure trays, and others), guidance technique (ultrasound-guided biopsy, stereotactic-guided biopsy, MRI-guided biopsy, and others), application (breast biopsy, lung biopsy, colorectal biopsy, prostate biopsy, and others), end use (hospitals, academic and research institutes, and diagnostic and imaging centers), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
• Market Report

Table of Contents

1. Executive Summary

2. Global Biopsy Device Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Biopsy Device Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Biopsy Device Market by Product
  • 3.3.1: Needle-Based Biopsy Devices
  • 3.3.2: Localization Wires
  • 3.3.3: Procedure Trays
  • 3.3.4: Others
• 3.4: Global Biopsy Device Market by Guidance Technique
  • 3.4.1: Ultrasound-Guided Biopsy
  • 3.4.2: Stereotactic-Guided Biopsy
  • 3.4.3: MRI-Guided Biopsy
  • 3.4.4: Others
• 3.5: Global Biopsy Device Market by Application
  • 3.5.1: Breast Biopsy
  • 3.5.2: Lung Biopsy
  • 3.5.3: Colorectal Biopsy
  • 3.5.4: Prostate Biopsy
  • 3.5.5: Others
• 3.6: Global Biopsy Device Market by End Use
  • 3.6.1: Hospitals
  • 3.6.2: Academic and Research Institutes
  • 3.6.3: Diagnostic and Imaging Centers

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Biopsy Device Market by Region
• 4.2: North American Biopsy Device Market
  • 4.2.1: North American Biopsy Device Market by Product: Needle-Based Biopsy Devices, Localization Wires, Procedure Trays, and Others
  • 4.2.2: North American Biopsy Device Market by Application: Breast Biopsy, Lung Biopsy, Colorectal Biopsy, Prostate Biopsy, and Others
• 4.3: European Biopsy Device Market
  • 4.3.1: European Biopsy Device Market by Product: Needle-Based Biopsy Devices, Localization Wires, Procedure Trays, and Others
  • 4.3.2: European Biopsy Device Market by Application: Breast Biopsy, Lung Biopsy, Colorectal Biopsy, Prostate Biopsy, and Others
• 4.4: APAC Biopsy Device Market
  • 4.4.1: APAC Biopsy Device Market by Product: Needle-Based Biopsy Devices, Localization Wires, Procedure Trays, and Others
  • 4.4.2: APAC Biopsy Device Market by Application: Breast Biopsy, Lung Biopsy, Colorectal Biopsy, Prostate Biopsy, and Others
• 4.5: ROW Biopsy Device Market
  • 4.5.1: ROW Biopsy Device Market by Product: Needle-Based Biopsy Devices, Localization Wires, Procedure Trays, and Others
  • 4.5.2: ROW Biopsy Device Market by Application: Breast Biopsy, Lung Biopsy, Colorectal Biopsy, Prostate Biopsy, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Biopsy Device Market by Product
  • 6.1.2: Growth Opportunities for the Global Biopsy Device Market by Guidance Technique
  • 6.1.3: Growth Opportunities for the Global Biopsy Device Market by Application
  • 6.1.4: Growth Opportunities for the Global Biopsy Device Market by End Use
  • 6.1.5: Growth Opportunities for the Global Biopsy Device Market by Region
• 6.2: Emerging Trends in the Global Biopsy Device Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Biopsy Device Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Biopsy Device Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Cook Medical
• 7.2: Boston Scientific
• 7.3: Fujifilm
• 7.4: Cardinal Health
• 7.5: Danaher